VJHemOnc is committed to improving our service to you

iwCLL 2019 | Five-year follow up of the UK CLL Forum ibrutinib data

VJHemOnc is committed to improving our service to you

George Follows

George Follows, BCh, PhD, FRCP, FRCPath, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, updates us on the UK CLL Forum 5-year follow up data for ibrutinib in R/R chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter